We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 41-60 of 8,521 results
  1. Aberrant expression of GSTM5 in lung adenocarcinoma is associated with DNA hypermethylation and poor prognosis

    Background

    Glutathione-S transferases (GSTs) comprise a series of critical enzymes involved in detoxification of endogenous or xenobiotic compounds....

    Xuewei Hao, Jun Zhang, ... Shuo Chen in BMC Cancer
    Article Open access 21 June 2022
  2. Bacteria pathogens drive host colonic epithelial cell promoter hypermethylation of tumor suppressor genes in colorectal cancer

    Background

    Altered microbiome composition and aberrant promoter hypermethylation of tumor suppressor genes (TSGs) are two important hallmarks of...

    **aoxuan **a, William Ka Kei Wu, ... Jun Yu in Microbiome
    Article Open access 16 July 2020
  3. Hypermethylation of TMEM240 predicts poor hormone therapy response and disease progression in breast cancer

    Background

    Approximately 25% of patients with early-stage breast cancer experience cancer progression throughout the disease course. Alterations in TMEM240...

    Ruo-Kai Lin, Chih-Ming Su, ... Chin-Sheng Hung in Molecular Medicine
    Article Open access 17 June 2022
  4. Hypermethylation of PDX1, EN2, and MSX1 predicts the prognosis of colorectal cancer

    Despite numerous observations regarding the relationship between DNA methylation changes and cancer progression, only a few genes have been verified...

    Yeongun Lee, So Hee Dho, ... Lark Kyun Kim in Experimental & Molecular Medicine
    Article Open access 15 February 2022
  5. Pervasive promoter hypermethylation of silenced TERT alleles in human cancers

    Background

    In cancers, maintenance of telomeres often occurs through activation of the catalytic subunit of telomerase, encoded by TERT . Yet, most...

    David Esopi, Mindy Kim Graham, ... Srinivasan Yegnasubramanian in Cellular Oncology
    Article Open access 28 May 2020
  6. Promoter Hypomethylation Upregulates ANXA2 Expression in Pancreatic Cancer and is Associated with Poor Prognosis

    Pancreatic cancer (PC) is one of the world’s most aggressive and deadly cancers, owing to non-specific early clinical symptoms, late-stage diagnosis,...

    Soumaya Menadi, Burak Kucuk, Ercan Cacan in Biochemical Genetics
    Article 24 November 2023
  7. Promoter methylation-regulated miR-148a-3p inhibits lung adenocarcinoma (LUAD) progression by targeting MAP3K9

    Lung adenocarcinoma (LUAD) characterized by high metastasis and mortality is the leading subtype of non-small cell lung cancer. Evidence shows that...

    Lu Liang, Wen-yan Xu, ... **-yong Yu in Acta Pharmacologica Sinica
    Article 06 April 2022
  8. PCDH17 gene promoter methylation status in a cohort of Egyptian women with epithelial ovarian cancer

    Background and objective

    Ovarian cancer is a leading cause of female mortality. Epigenetic changes occur in early stages of carcinogenesis and...

    Sherif Mohamed Elsharkawi, Dalal Elkaffash, ... Raghda Saad Zaghloul Taleb in BMC Cancer
    Article Open access 25 January 2023
  9. M2 Macrophage-Derived Exosomes Regulate miR-199a-3p Promoter Methylation Through the LINC00470-Mediated myc/DNMT3a Axis to Promote Breast Cancer Development

    Breast cancer (BC) is the most common invasive cancer in women. M2 macrophage exosomes promote cancer development and play multiple roles in the...

    Dachang Ma, Jun Wu, ... Quanlin Guan in Biochemical Genetics
    Article 18 October 2023
  10. Hypermethylation of heparanase 2 promotes colorectal cancer proliferation and is associated with poor prognosis

    Background

    The epigenetic abnormality of tumor-associated genes contributes to the pathogenesis of colorectal carcinoma (CRC). However, methylation in...

    Hui Zhang, Chenxin Xu, ... Jifeng Feng in Journal of Translational Medicine
    Article Open access 05 March 2021
  11. The prognostic value and immune correlation of IL18 expression and promoter methylation in renal cell carcinoma

    Background

    Renal cell carcinoma (RCC) is not sensitive to immunotherapy and has poor prognosis. DNA methylation regulates gene expression, and its...

    **aonan Wang, Wancui Zhu, ... Wuguo Deng in Clinical Epigenetics
    Article Open access 28 January 2023
  12. BDNF exon IV promoter methylation and antidepressant action: a complex interplay

    Background

    BDNF exon IV promoter methylation is a potential biomarker for treatment response to antidepressants in MDD. We have previously shown...

    Hansi Pathak, Anton Borchert, ... Helge Frieling in Clinical Epigenetics
    Article Open access 26 December 2022
  13. Aberrant hydroxymethylation in promoter CpG regions of genes related to the cell cycle and apoptosis characterizes advanced chronic myeloid leukemia disease, poor imatinib respondents and poor survival

    Background

    There is strong evidence that disease progression, drug response and overall clinical outcomes of CML disease are not only decided by...

    Sameer Ahmad Guru, Mamta Pervin Sumi, ... Alpana Saxena in BMC Cancer
    Article Open access 14 April 2022
  14. Hypermethylation of Long Non-Coding RNA Genes Group in the Breast Cancer Development and Progression

    We analyzed changes in the level of methylation of CpG islands in four long non-coding RNA (lncRNA) genes MEG3 , ZNF667-AS1 , GAS5 , and SEMA3B-AS1 as...

    A. D. Selezneva, E. A. Filippova, ... V. I. Loginov in Bulletin of Experimental Biology and Medicine
    Article 01 October 2022
  15. SOX14 hypermethylation as a tumour biomarker in cervical cancer

    Background

    The association between SOX14 and cancer has been reported. The aim of this study was to identify and validate the potential value of SOX14...

    **g Zhao, Huiling Cao, ... Rong Wang in BMC Cancer
    Article Open access 07 June 2021
  16. The influence of Nrf2 gene promoter methylation on gene expression and oxidative stress parameters in preeclampsia

    Background and aims

    Preeclampsia (PE) is a serious medical condition that usually causes high blood pressure and affects multiple organs. Considering...

    Saba Zakeri, Zohreh Rahimi, ... Kheirolah Yari in BMC Medical Genomics
    Article Open access 28 February 2024
  17. CpG Methylation of the Proximal Promoter Region Regulates the Expression of NAC6D Gene in Response to High Temperature in Wheat (Triticum aestivum)

    Abstract

    Methylation of DNA promoter sequences at the CpG islands has become a molecular tool for gene regulation. NAC6D gene is induced by different...

    A. M. El-Shehawi, M. A. Elseehy, M. M. Elseehy in Cytology and Genetics
    Article 20 September 2022
  18. Evaluating the link between DIO3-FA27 promoter methylation, biochemical indices, and heart failure progression

    Background

    Heart failure (HF) is a disease that poses a serious threat to individual health, and DNA methylation is an important mechanism in...

    Yan Qi, **angchao Meng, ... Rongqiang Zhang in Clinical Epigenetics
    Article Open access 24 April 2024
  19. Inhibitory immune checkpoints PDCD-1 and LAG-3 hypermethylation may reduce the risk of colorectal cancer

    Background

    Changes in DNA methylation of immunosuppressive checkpoints may impact express and consequently affect antigen processing and presentation...

    Yuanyuan Zhang, Lei zhang, ... Guiyu Wang in Molecular Medicine
    Article Open access 20 September 2021
  20. DNA hypermethylation driven by DNMT1 and DNMT3A favors tumor immune escape contributing to the aggressiveness of adrenocortical carcinoma

    Background

    Adrenocortical carcinoma is rare and aggressive endocrine cancer of the adrenal gland. Within adrenocortical carcinoma, a recently...

    Gwenneg Kerdivel, Floriane Amrouche, ... Valentina Boeva in Clinical Epigenetics
    Article Open access 02 August 2023
Did you find what you were looking for? Share feedback.